Improving cell transplantation after spinal cord injury: When, where and how?

June 10, 2016 – Spinal cord injuries are mostly caused by trauma, often incurred in road traffic or sporting incidents, often with devastating and irreversible consequences, and unfortunately having a relatively high prevalence. One currently explored approach to restoring function after spinal cord injury is the transplantation of olfactory ensheathing cells (OECs) into the damaged area. The hope is that these will encourage the repair of damaged neurons, but does it work? And if so, how can it be optimised?

According to a systematic analysis of the literature published this week in PLOS Biology, after experimental spinal cord injury, transplanting OECs into the site of damage does indeed significantly improve locomotor performance. To reach this conclusion, Ralf Watzlawick, Jan Schwab, and their colleagues at the Ohio State University Wexner Medical Center, Charité Universtaetsmedizin Berlin and the CAMARADES consortium (Collaborative Approach to Meta Analysis and Review of Animal Data from Experimental Studies), analysed 49 studies, published between 1949 and 2014, which included 62 experiments involving 1164 animals.

Restoration of function after spinal cord injury remains one of the most formidable challenges in regenerative medicine, but cell transplantation into the spinal cord represents a promising treatment strategy. OECs are considered particularly suitable for transplantation because they have been shown to be neuro-protective and to promote neuro-regeneration in different settings, and can be extracted from the patient’s own nasal cavity, thereby minimizing the chances of graft rejection and avoiding the need for immunosuppressive drugs.

However, reports in the literature about the efficacy of transplantation of OECs for treatment of spinal cord injury have been contradictory. Therefore, to investigate the in vivo evidence for the efficacy of this procedure, the authors implemented a systematic review and meta-analysis of the literature. Importantly, the authors set out to explore the potential influence of variations in experimental approaches and unreported data.

“We felt that after more than two decades since the discovery that OECs elicit effects on neural plasticity in vivo, it was time to test their effects by appropriate methodology beyond reproduction”, the authors argued.

The data analysed by the authors justify the use of OECs as a cellular substrate to develop and to optimize minimally invasive and secure protocols for repairing damaged spinal cord. They also identified several aspects of the cell transplantation procedure that could have a significant impact on the size of the therapeutic effect, including: the time-point of application, the use of surgical micro-dissection to “refresh” the scar tissue, the localization of transplanted cells, the number of injections, the injected volume, and the dose of cells administered.

Importantly, by using state-of-the-art statistical methods the authors also found that the impact of publication bias (due to selective failure to report results) was minimal, further supporting the translational potential of this approach.

Despite being focussing on OECs, the findings may be of more general relevance for optimising the transplantation of other cell types after spinal cord injury.

Source: Science Daily

Reference: Ralf Watzlawick, Julian Rind, Emily S. Sena, Benedikt Brommer, Tian Zhang, Marcel A. Kopp, Ulrich Dirnagl, Malcolm R. Macleod, David W. Howells, Jan M. Schwab. Olfactory Ensheathing Cell Transplantation in Experimental Spinal Cord Injury: Effect size and Reporting Bias of 62 Experimental Treatments: A Systematic Review and Meta-Analysis.PLOS Biology, 2016; 14 (5): e1002468 DOI: 10.1371/journal.pbio.1002468